Beyond Avoidance: Omalizumab and the Evolving Care of Pediatric Food Allergy.

Xolair (omalizumab) - Roche, Novartis

Beyond Avoidance: Omalizumab and the Evolving Care of Pediatric Food Allergy. (PubMed, Pediatr Ann) - Oct 7, 2026 - No abstract available
Journal • Allergy • Food Hypersensitivity • Immunology • Pediatrics

http://www.ncbi.nlm.nih.gov/pubmed/42837581

Joseph R Hageman; Lolita Alcocer Alkureishi; Sai R Nimmagadda

Oct 7, 2026